Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 48

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 48
---
’s financial condition, results of operations, credit rating or
liquidity. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates
and opinions or other circumstances should change, except as may be required by applicable United States and Canadian securities laws. Readers are cautioned against attributing undue certainty to forward-looking statements.

25

PROPOSAL NO. 1 — ARRANGEMENT RESOLUTION

At the Special Meeting, our Shareholders will be asked to consider and, if thought advisable, to pass, with or without variation, the
Arrangement Resolution, the full text of which is set forth in Annex D to this Circular and Proxy Statement, approving the Arrangement under Chapter XVI – Division II of the QBCA involving the Company and the Purchaser, pursuant to which,
among other things, the Purchaser will acquire all of the issued and outstanding Common Shares of the Company and the Shareholders will receive (a) a cash amount per Common Share, which is currently estimated to be approximately $1.82 per
Common Share and will be finally determined based upon the Company’s cash balance immediately prior to the Closing after deducting certain transaction costs, the aggregate amount of outstanding liabilities, and a transaction fee to the
Purchaser, and (b) one CVR for each Common Share that will entitle the holder to receive, following Closing, contingent cash payments described in, and subject to and in accordance with the terms and conditions of, the CVR Agreement.

Approval of the Arrangement Resolution requires the affirmative vote of not less than (i) 66⁄% of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special Meeting, and (ii) a simple majority of the votes attached to Common Shares held by Shareholders
present in person (virtually) or represented by proxy at the Special Meeting excluding for this purpose votes attached to Common Shares held by persons described in items (a) through (d) of section 8.1(2) of MI
61-101.

The Board unanimously recommends that the Shareholders vote “FOR” the Arrangement Resolution.

26

THE ARRANGEMENT This section of this Circular and Proxy Statement describes the material aspects of the Arrangement. This discussion of the Arrangement is qualified in its entirety by reference to the Agreement, a copy of which is attached to this Circular and Proxy Statement as Annex A